Recursion Pharmaceuticals Inc - Ordinary Shares - Class A XNAS: RXRX

Recursion Pharmaceuticals Inc - Ordinary Shares - Class A Live Share Price Today, Share Analysis and Chart

Name: Recursion Pharmaceuticals Inc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Recursion Pharmaceuticals Inc - Ordinary Shares - Class A
Rating: 1.00879175
Author: Trendlyne DVM scores

Momentum Trap

Download real time

5.81 -0.16 (-2.68%)

Near 52W Low of $5.60

15.0M XNAS Volume

XNAS 28 Mar, 2025 5:30 PM (EDT)

Low Financial Strength

16.7 / 100

Expensive Valuation

10.0 / 100

Technically Neutral

37.4 / 100

Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

9

1Yr Price target upside is 55%

7 analysts

Recursion Pharmaceuticals ... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Recursion Pharmaceuticals Inc - Ordinary Shares - Class A FAQ

How is Recursion Pharmaceuticals Inc - Ordinary Shares - Class A today?

Recursion Pharmaceuticals Inc - Ordinary Shares - Class A today is trading in the red, and is down by -2.68% at 5.81.

How has Recursion Pharmaceuticals Inc - Ordinary Shares - Class A performed historically?

Recursion Pharmaceuticals Inc - Ordinary Shares - Class A is currently trading down -2.68% on an intraday basis. In the past week the stock fell -13.02%. stock has been down -21.38% in the past quarter and fell -41.73% in the past year. You can view this in the overview section.